Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

320

HTML

2127

Figures (1-2)

242

Tables (1-3)

216

Sum=2905

Dec 14, 2008 (publication date) through Nov 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 14, 2008; 14(46): 7117-7121
Published online Dec 14, 2008. doi: 10.3748/wjg.14.7117

Figure 1 APRI and fibrosis stage in CHB patients with their ALT ≥ 2ULN (A) or < 2ULN (B).

Figure 2 HA and fibrosis stage in CHB patients with their ALT ≥ 2ULN (A) or < 2ULN (B).

Citation: Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(46): 7117-7121
URL: https://www.wjgnet.com/1007-9327/full/v14/i46/7117.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7117